| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 9,636,621 | 10,939,051 | 7,756,362 | | Cost of Revenue | 1,724,070 | 2,663,883 | 1,680,167 | | | Gross Profit | 7,912,551 | 8,275,168 | 6,076,195 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,572,475 | 4,660,351 | 3,314,031 | | Non Recurring | 6,085,000 |
-
|
-
| | Others | 2,191,139 | 563,553 | 142,500 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,936,063) | 3,051,264 | 2,619,664 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,936,063) | 3,051,264 | 2,619,664 | | Interest Expense | 996,364 | 1,012,414 | 660,649 | | Income Before Tax | (5,932,427) | 2,038,850 | 1,959,015 | | Income Tax Expense | (348,114) | 645,687 | 605,870 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,584,313) | 1,393,163 | 1,353,145 | | | Non-recurring Events | | Discontinued Operations | (11,461) | (142,068) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,595,774) | 1,251,095 | 1,353,145 | | Preferred Stock And Other Adjustments | (26,236) |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,622,010) | $1,251,095 | $1,353,145 |
|
1.52% Nasdaq 0.00%
Income Statement
